Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

March 24, 2022

Berlin named interim leader of Hematology and Oncology

Jordan Berlin, MD, has been appointed interim leader of Vanderbilt’s Division of Hematology and Oncology in the Department of Medicine.

By Tom Wilemon
March 22, 2022

VUMC’s Pietenpol, Shyr named AACR Fellows

Vanderbilt’s Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

By Tom Wilemon
March 11, 2022

New Clinician Spotlight: Jeffrey Tosoian

Jeffrey Tosoian, MD, MPH, joined the Department of Urology at Vanderbilt University Medical Center recently after completing his fellowship at the University of Michigan.

By VUMC News and Communications
March 10, 2022

Bots boost liver cancer outcome

Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.

By Leah Mann 
Lawrence Marnett, PhD, left, and Jennifer Pietenpol, PhD, right, presented 2021 Research Staff Awards to Kimberly Newsom, second from left, Tracie Baker, CCRP, and Pavlo Gilchuk, PhD.
March 9, 2022

Research Staff Awards honor those who help drive science forward

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony.

By Bill Snyder
As an 11-year cancer survivor, Lori Martin, BSN, MBA, RT(R), knows firsthand the importance of colorectal cancer screening.
March 9, 2022

Martin shares colorectal cancer story, urges early detection

Vanderbilt Wilson County Hospital’s Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer.

By Tom Wilemon
March 7, 2022

Study finds World Trade Center responders at higher risk for blood cancer-associated mutations

A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease
By Tom Wilemon
February 24, 2022

Melanoma treatment response

Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found.
By Sarah E. Glass
February 17, 2022

Park named director of Vanderbilt-Ingram Cancer Center

Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.
By John Howser
February 17, 2022

Grant to support Haake’s research on kidney cancer

Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.
By Tom Wilemon
February 10, 2022

Pietenpol named chief scientific and strategy officer

Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership role for VUMC as chief scientific and strategy officer (CSSO).
By John Howser
February 3, 2022

Osterman plays key role in major oncology EHR initiative

Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.
By Tom Wilemon
January 27, 2022

New fund supports appendiceal cancer research

By Tom Wilemon
1 … 6 7 8 9 10 … 55